Nuclear Medicine Physician
[§ 361.1(c)(1)]
A physician recognized as a specialist in nuclear medicine.
Alert: Microsoft Outlook Outage
CU Denver is aware of issues with Microsoft email today. The issue appears to be international in scope. You may experience:
- Inability to send or receive email
- Delayed message delivery
- Authentication failures when accessing Exchange Online services
- Intermittent mailbox access issues
- Administrative portal performance issues related to Exchange
Microsoft has acknowledged the incident and is investigating. No ETA on resolution yet. For updates visit:
For updates visit: Anschutz ISS and CU Denver OIT Status.
CU Denver is aware of issues with Microsoft email today. The issue appears to be international in scope. You may experience:
- Inability to send or receive email
- Delayed message delivery
- Authentication failures when accessing Exchange Online services
- Intermittent mailbox access issues
- Administrative portal performance issues related to Exchange
Microsoft has acknowledged the incident and is investigating. No ETA on resolution yet. For updates visit:
For updates visit: Anschutz ISS and CU Denver OIT Status.
Learn More
Radioactive Drug Research Committee (RDRC)
The Radioactive Drug Research Committee operates under the purview of the Food and Drug Administration in accordance with
FDA regulation 21 CFR 361.1 . The Committee reviews, approves, and provides ongoing oversight of research studies involving radioactive drugs in humans that fall under the RDRC's purview, as defined in FDA regulation 21 CFR 361.1.
The Committee meets quarterly and is made up of at least five individuals as follows:
Radioactive Drugs Specialist
[§ 361.1(c)(1)]
A person qualified by training and experience to formulate radioactive drugs.Radiation Safety Expert
[§ 361.1(c)(1)]
A person with special competence in radiationsafety anddosimety.Qualified Individuals
[§ 361.1(c)(1)]
Individuals qualified in various disciplines pertinent​ to the field of nuclear medicineApproved qualified investigators require both RDRC approval and the approval of the IRB before the study may begin.
If you have any questions please contact Radiation Committee Coordinator at 303-724-4743 or send an email to RDRC@cuanschutz.edu.
If you have any questions please contact Radiation Committee Coordinator at 303-724-4743 or send an email to RDRC@cuanschutz.edu.
.jpg?sfvrsn=4b5e6cba_0 "benjamin-child-GWe0dlVD9e0-unsplash")
Next RDRC Meeting
TBA